Ocular Therapeutix, Inc.
(NASDAQ : OCUL)

( )
OCUL After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
3.37%15.661.8%$144.53m
VRXValeant Pharmaceuticals International, Inc.
2.47%21.8314.1%$128.45m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.01%154.176.2%$82.55m
PRGOPerrigo Co. Plc
1.95%47.086.8%$73.13m
SAGESAGE Therapeutics, Inc.
1.45%164.358.6%$64.64m
JAZZJazz Pharmaceuticals Plc
0.68%135.752.3%$53.95m
HZNPHorizon Pharma plc
1.85%27.506.7%$44.87m
PTLAPortola Pharmaceuticals, Inc.
-1.51%29.957.5%$43.46m
UTHRUnited Therapeutics Corporation
0.55%81.8214.3%$42.45m
ICLRICON Plc
0.13%157.374.1%$38.97m
ICPTIntercept Pharmaceuticals, Inc.
3.45%66.2117.2%$37.20m
CTLTCatalent Inc
0.70%56.232.4%$36.67m
MDCOMedicines Company
1.44%33.1820.3%$34.12m
AERIAerie Pharmaceuticals, Inc.
2.98%23.886.8%$25.84m
PCRXPacira Pharmaceuticals, Inc.
-0.84%37.9010.5%$24.49m

Company Profile

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.